FDA to Evaluate Homeopathy Regulatory Framework

Reuters reports that the U.S. Food and Drug Administration will hold a public hearing seeking information and comments on the use of homeopathic products, as well as the agency’s framework for such products:

The hearing, scheduled for April 20-21, will discuss prescription drugs, biological products, and over-the-counter drugs labeled homeopathic, a market that has expanded to become a multimillion dollar industry in the United States.

The agency is set to evaluate its regulatory framework for homeopathic products after a quarter century.

You can read the FDA’s announcement here.